Abstract Submission Guidelines

HTAi 2019 Annual Meeting Submission Guidelines – Download Version

Overall Scientific Theme and Program

HTA beyond 2020: Ready for the New Decade?

One year ahead of the end of several prominent HTA strategies and projects, the course will (and has to) be set for future development of HTA worldwide in 2020 and beyond. Therefore, the preliminary results will fuel the debate about the future of HTA.

Besides many important strategies and projects dealing with HTA, there are some prominent ones such as HTAi’s own strategy paper, accompanied by Horizon 2020, the main research program of the EU Commission, and the EUnetHTA Joint Action 3 project, the proposal of the EU-Commission for a regulation on HTA in Europe after 2020. Other key scientific programs like IC-Permed, the international consortium for personalized medicine, will be more important than ever. The discussion about subsequent strategies, projects, developments and changes as a result of these projects will be starting in 2019.

The HTAi Annual Meeting provides an ideal presentation and discussion platform for opportunities, emerging challenges and possible threats. Trends for harmonization and standardization are confronted by progressive digitalization, disruptive innovations and the questioning of established evidence requirements. The European proposal for “HTA after 2020” might stand exemplarily for the important international strategic efforts to strengthen HTA for the new decade. Furthermore, globalization takes place and HTA becomes much more important for emerging markets. 2019 is the perfect time to tie this “varicolored bouquet” of important HTA developments together, looking into the future and asking: HTA beyond 2020: Ready for a New Decade?

 

The overarching topic “HTA beyond 2020” is characterized by three plenary sessions:

Plenary 1:    HTA Beyond 2020:

                        One Size Fits All? Will Joint International Assessments Improve Or Hinder HTA?

Plenary 2:    HTA Beyond 2020: The Era Of Digitalization?

Plenary 3:    HTA Beyond 2020: Need For Smart Capability Building?

 

The Annual Meeting in Cologne will provide an opportunity to consider the following themes and topics in workshops, panels, oral presentations, vignettes and posters:

 

HTA Beyond 2020: One Size Fits All? Will Joint International Assessments Improve Or Hinder HTA?

In HTA models, the conflict between the consensus that study methodology and HTA evaluations should apply regardless of context and the importance of context-dependent HTA decisions is evident in discussions of the new phase of international HTA collaboration in the EU. Those in favour of joint cross-country assessments based on joint methodologies and requirements argue that such collaborations have potential to increase availability of HTA reports as well as high-quality “real world” data. Opponents, however, are concerned that usefulness for decision-makers at various levels will decrease as the context-specificity is reduced and/or lost.

For more details on Plenary 1, please follow this LINK.

 

HTA Beyond 2020: The Era Of Digitalisation?

Digitalization offers many new treatment, diagnostic, and research options as well as tools like smart medical devices, mobile apps, and telehealth. It is not clear yet whether new digital health interventions can and should be assessed by using ‘conventional’ HTA methodology. On the other hand, HTA could directly benefit from digitalization, since the availability of digital data might allow for faster and more detailed research and evaluation. Even HTA processes themselves could be digitized and automated. In summary, there are many opportunities but also challenges for HTA arising from digitalization.

For more details on Plenary 2, please follow this LINK.

 

HTA Beyond 2020: Need For Smart Capability Building?

As the year 2020 approaches, HTA capabilities may be required to adapt and change to meet evolving stakeholder expectations, data and evidence availability, and biomedical and healthcare service innovations. New capabilities required to produce effective HTA may include, for example, new methodology development, capacity building, and horizon scanning, among others. Given that healthcare systems are already resource constrained, developing additional HTA capabilities will require the HTA community and institutions to implement smart capability building. In summary, critical success factors and best practices will be instrumental to guide smart capability building for HTA beyond 2020.

For more details on Plenary 3, please follow this LINK.

 

Abstract Submissions

When submitting abstracts, applicants will be asked to select topic areas from the list below to identify the one that most closely matches the theme of their abstract. Reviewers will identify their area of expertise based on this same list of topics — this ensures that knowledgeable reviewers assess all abstracts.

As the conference focuses on “HTA beyond 2020”, it is recommended to submit abstracts leaning on one of the plenary themes by, for example, dealing with capability building, digitalization, HTA in EU and emerging markets as well as other scenarios after 2020.

HTAi will also look to ensure that at the conference there is a strong presence of patients, students and presenters from Low and Middle-Income Country (LMIC).

List of topic areas for abstracts:

1) Processes in HTA

    a. Research on HTA Methods, Including Novel Methods for Conducting HTA (e.g., Rapid Reviews, Adapting Existing HTAs)
    b. Horizon Scanning
    c. Information Retrieval
    d. Evidence Quality Including Bias, Transferability and Generalisability
    e. Clinical Effectiveness
    f. Big Data Analysis and Use of Real World Data For HTA
    g. Costs and Economic Evaluation
    h. Ethical, Social, Legal and Environmental Aspects of HTA
    i. HTA Prioritization

2) Policy Issues In HTA

    a. Globalisation
    b. Regulatory-HTA Alignment
    c. Value-Based Health Policy and Value Frameworks
    d. Reassessment and Disinvestment
    e. Capacity Building in HTA, Enhancing Skills and Capabilities at Country Level
    f. Country-Specific HTA and Regional HTA Networks
    g. Comparative HTA Systems and Emerging Markets

3) Hospital-Based HTA

    a. HTA and Procurement
    b. HTA and Health Technology Management

4) HTA and Clinical Practice Guidelines

5) Stakeholder Involvement in HTA

    a. Patient Involvement
    b. Public Involvement
    c. HTA and Shared Decision-Making
    d. Engagement of Health Care Professionals
    e. HTA in the Media and Including Specialist and General Media and Social Media

6) HTA – Presenting Results of HTAs

    a. Pharmaceuticals
    b. Medical Devices
    c. Public Health Interventions (e.g., Vaccines, Screening Programs)
    d. Procedures and Other Interventions (e.g., Surgery)
    e. Tests: Predictive or Diagnostic, Precision and Personalized Medicine and Companion Diagnostics
    f. Social Services
    g. E-Health and M-Health

7) Other Topics

 

Panel and Workshop Submissions

Oral, Vignette and Poster Submissions

 

General Information

Submission deadlines

Submission deadlines are different based on submission type. Please note below the important dates regarding abstract submissions and be advised that no extensions to these deadlines will be made.

Open Call for Abstracts: August, 2018

Deadline for Workshop and Panel submissions: October 4, 2018
Acceptance notification: November 9, 2018

Deadline for Oral, Vignette and Poster Presentation submissions: November 16, 2018
Acceptance notification: February 1, 2019

Receipt of abstract submission will be acknowledged via e-mail prior to submission close for each category.

 

Submission Details

a) General submission details:

b) Workshop and Panel submission details:

 

c) Oral, Vignette and Poster submission details:

 

Review, acceptance, notification and final inclusion in the official Program

a) Review:

All abstracts will be peer reviewed by three experts identified by the HTAi International Scientific Program Committee (ISPC). Panel and workshop submissions will be reviewed by members of the ISPC. Oral, vignette and poster submissions will be reviewed by a broad group of reviewers, coordinated by the HTAi Secretariat, which will include ISPC members and a selected group of experts in the HTA field. Final decisions about inclusion and organization of the program will be made by the ISPC, led by the ISPC Co-Chairs.

 

b) Abstract acceptance and notifications:

Workshops and Panels: After review, the abstract’s primary contact will receive an email notification indicating the abstracts acceptance or rejection by November 9, 2018. Registration for the Annual Meeting must be submitted by March 22, 2019 (early bird registration deadline), to ensure inclusion in the Annual Meeting program.

Oral, Vignette and Poster Presentations: After review, the abstract’s primary contact will receive an email notification indicating the abstract’s acceptance or rejection by February 1, 2019. Registration for the Annual Meeting must be submitted by March 22, 2019 (Early Bird Registration Deadline), to ensure inclusion in the Annual Meeting program.

 

c) Final inclusion in the official Annual Meeting Program:

Workshops and Panels: Until the Early Bird Deadline (March 22, 2019), at least one of the named chairs/moderators must be registered for the Annual Meeting to confirm the final inclusion in the official Annual Meeting Program. Panels and Workshops which do not fulfill this requirement will be withdrawn from the program.

Oral, Vignette and Poster Presentations: Until the Early Bird Deadline (March 22, 2019), the abstract’s primary presenter must be registered for the Annual Meeting to confirm the final inclusion in the official Annual Meeting Program. Oral, Vignette and Poster Presentations which do not fulfill this requirement will be withdrawn from the program.

 

4) Publication of abstract content

a) Annual Meeting Materials:

Submission of abstracts constitutes all authors’ consent to have their abstracts published on the HTAi 2019 website, mobile app, within the program and abstract book.

Please review your abstract prior to submission; check grammar and spelling and ensure all special characters and formatting display correctly. Accepted abstracts will be published in the Annual Meeting Materials (e.g. website, mobile app, program and abstract book) as submitted. Changes to abstracts will not be accepted after the Submission Deadline.

 

b) Supplementary Issue of the International Journal of Technology Assessment in Health Care:
Accepted abstracts of Oral, Vignette and Poster presentations have the possibility to be published in a Supplementary Issue of the International Journal of Technology Assessment in Health Care. Abstract submitters will be able to provide their consent for publication in the abstract submission form. Once abstracts have been accepted for the official program, there will be an editing process and if any major changes are recommended these will be communicated to the abstract submitter (primary contact). If authors would like to have their abstracts to go into the Supplement of IJTAHC then a fully completed copyright form must accompany the submission. Link to the Copyright Assignment Form. The Supplementary Issue will be published ahead of the meeting.

 

Scoring Criteria

The scoring system applied to all abstracts will take into consideration gender balance, the involvement of students and contributions from people from Low and Middle-Income Country (LMIC) as well as patients, users and clients.

 

1) Appropriateness to HTAi

The concept of the abstract should be appropriate to HTAi and in alignment with the main themes of the Annual Meeting. Panels and workshops should have presenters who are knowledgeable about the subject matter and, collectively, represent a variety of different perspectives and/or settings.

 

2) Original and Innovative Contribution

Abstracts with original and innovative ideas will receive a higher score. In particular:

challenging existing paradigms or HTA practice,

addressing an innovative hypothesis or critical barriers/issues to progress, and

developing or enhancing novel concepts, approaches or methodologies, tools or technologies for this area

 

3) Abstract Structure and Quality

a) Workshop and panel abstracts must have the following structure:

Title: must not exceed 100 characters, with no abbreviations and the beginning of each word is capitalized.

Introduction: Include the scientific background and rationale for the panel or workshop, and a clear statement of the issue. Must be clearly stated to achieve the highest score.

Structure of the session: Give the structure of your workshop/panel (e.g. presenters, timing, format of interaction, etc.) and your plans to generate a vibrant discussion or learning environment.

Panel/Workshop outcome and objectives: Explain what you would like to accomplish during your workshop/panel session, the session’s contribution to HTA capacity building as well as the benefits and takeaways for the audience or participants.

Moderators/Presenters: Include name, organization, position of all presenters, as well as the title (or brief description) of their specific contribution. Only confirmed moderators/presenters can be submitted with your application.

Declaration of funding: Please declare sources of funding of the research.

Basic quality: Workshops and panel abstracts should be appropriately summarised, and grammar and spelling should be checked.


b) Oral, vignette and poster abstracts must have the following structure:

Title: must not exceed 70 characters, with no abbreviations and the beginning of each word is capitalized.

Introduction: Include the scientific background and rationale, and give a clear statement of the problem, issue, study goal, objectives, and/or research hypothesis. Must be clearly stated to achieve the highest score.

Methods: For quantitative and related studies, include a clear statement of the perspective, data collected, sources of data, analyses including statistical testing, etc. Clearly describe the populations studied, method of accrual and sample frame and analytical techniques. For conceptual, institutional, organizational or policy papers, provide a concise description of the content of the paper or report to be presented and other relevant factors such as policy analysis of alternatives, details of qualitative methods, etc.

Results: Present the most important study findings including generalisability to other populations, health systems or countries if relevant. Abstracts must reflect work that has already been done (i.e. results available) or at least provide preliminary results suggesting that the work is in progress and that results will be available to present at the Annual Meeting.

Conclusions: Provide a concise statement on the most important findings or policy implications.  You should also address the question, “What do these results mean for your main area of research?” If relevant, include next steps, proposals for further research and study limitations.

Declaration of funding: Please declare sources of funding of the research.

Basic quality: Oral, poster and vignette abstracts should be appropriately summarised, and grammar and spelling should be checked.

 

Style Guidelines

Please consider the following style guidelines as a general direction in the submission process to have the abstracts submitted as consistent and standardised for Annual Meeting publications (website, mobile app, program and abstract book). These guidelines are in line with those required for abstracts to be included in the Supplementary Issue of the International Journal of Technology Assessment in Health Care.

 

3 things to keep in mind:

  1. Abstracts with original and innovative ideas will receive higher scores.
  2. It is recommended that all abstracts featuring the future of HTA should consider the main topics capability building, digitalization as well as HTA in EU and emerging markets.
  3. Please read the submission guidelines carefully and thoroughly.